What sector does SAB Biotherapeutics Inc (SABS) operate in?
SAB Biotherapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is SAB Biotherapeutics Inc (SABS) current stock price?
As of the latest data, SAB Biotherapeutics Inc stock price is $3.85, with a previous close of $3.92. SAB Biotherapeutics Inc lost -$0.07 in the last trading session, representing a -1.79% loss.
What is SAB Biotherapeutics Inc (SABS) current market capitalization?
SAB Biotherapeutics Inc market cap is approximately 183.29 million.
What is SAB Biotherapeutics Inc (SABS) Earnings Per Share (EPS)?
The trailing EPS is -$1.56, and the forward EPS is -$0.33.
What is SAB Biotherapeutics Inc (SABS) EBITDA?
SAB Biotherapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -78.55 million.
Does SAB Biotherapeutics Inc (SABS) pay dividends?
No. SAB Biotherapeutics Inc does not pay a dividend.
What is SAB Biotherapeutics Inc (SABS) beta (volatility) score?
SAB Biotherapeutics Inc has a beta of 0.609, indicating lower volatility than the overall market.